SCHEMBL26435561

SCHEMBL26435561

c1cc(-c2nc(-c3ccc(-c4cc5ccccc5c5ccccc45)cc3)nc(-c3cccc4c3oc3ccccc34)n2)cc(-c2cccc3ccc4ccccc4c23)c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 2/20 0.43
GGPS1 O95749 1/20 0.36
CYP11B1 P15538 1/20 0.34
PRKDC P78527 2/20 0.34
PTGES2 Q9H7Z7 1/20 0.34
MAPT P10636 5/20 0.33
ALDH1A1 P00352 5/20 0.33
KDM4E B2RXH2 4/20 0.33
HPGD P15428 4/20 0.33
HSD17B10 Q99714 4/20 0.33
TSHR P16473 3/20 0.33
L3MBTL1 Q9Y468 3/20 0.33
MAPK1 P28482 2/20 0.33
TDP1 Q9NUW8 2/20 0.33
POLB P06746 1/20 0.33
TP53 P04637 1/20 0.33
NFKB1 P19838 1/20 0.33
NFKB2 Q00653 1/20 0.33
RELA Q04206 1/20 0.33
ATM Q13315 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26435606 0.94 ALOX5 (0.44) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435066 0.94 ALOX5 (0.43) ALOX5GGPS1CYP11B1PRKDCMAPT
SCHEMBL26435522 0.94 ALOX5 (0.49) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435654 0.93 ALOX5 (0.42) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435566 0.93 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435521 0.93 ALOX5 (0.45) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435462 0.92 ALOX5 (0.44) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL22889386 0.92 ALOX5 (0.49) ALOX5GGPS1CYP11B1PRKDCPTGES2
SCHEMBL26435479 0.92 ALOX5 (0.46) ALOX5GGPS1PRKDCPTGES2MAPT
SCHEMBL26435634 0.92 ALOX5 (0.44) ALOX5GGPS1PRKDCPTGES2MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) 2023-10-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230320205-A1 NITROGEN-CONTAINING COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND ELECTRONIC APPARATUS NOM1, MNS1, NOS1 ALOX5 1266/4885GGPS1 1604/4885CYP11B1 2325/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.